Literature DB >> 8036474

Chlamydia pneumoniae (TWAR): a common agent in acute bronchitis.

G Falck1, L Heyman, J Gnarpe, H Gnarpe.   

Abstract

Patients seeking medical attention for respiratory infections were investigated with serology and culture for Chlamydia pneumoniae to investigate the prevalence of C. pneumoniae in a specific geographical area and its association with respiratory disease. Evidence for C. pneumoniae infection was found in approximately 25% of cases. 71% of patients with C. pneumoniae had symptoms from the lower respiratory tract as compared to 29% of the others. We conclude that C. pneumoniae can be a major cause of acute bronchitis.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8036474     DOI: 10.3109/00365549409011782

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  12 in total

1.  Community epidemiology of Chlamydia and Mycoplasma pneumoniae in LRTI in France over 29 months.

Authors:  Jacques Gaillat; Antoine Flahault; Bertille deBarbeyrac; Jeanne Orfila; Henri Portier; Jean-Pierre Ducroix; Christiane Bébéar; Charles Mayaud
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 2.  Pathogenesis of lower respiratory tract infections due to Chlamydia, Mycoplasma, Legionella and viruses.

Authors:  P Andersen
Journal:  Thorax       Date:  1998-04       Impact factor: 9.139

3.  Association of Chlamydia pneumoniae IgA antibodies with recently symptomatic asthma.

Authors:  D L Hahn; T Anttila; P Saikku
Journal:  Epidemiol Infect       Date:  1996-12       Impact factor: 2.451

Review 4.  Chinese medicinal herbs for acute bronchitis.

Authors:  Lanhui Jiang; Ka Li; Taixiang Wu
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

Review 5.  Antibiotics for acute bronchitis.

Authors:  Susan M Smith; Tom Fahey; John Smucny; Lorne A Becker
Journal:  Cochrane Database Syst Rev       Date:  2017-06-19

6.  Age alterations in extent and severity of experimental intranasal infection with Chlamydophila pneumoniae in BALB/c mice.

Authors:  C Scott Little; Andrew Bowe; Richard Lin; Jason Litsky; Robert M Fogel; Brian J Balin; Kerin L Fresa-Dillon
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

7.  Chlamydia pneumoniae respiratory infections among patients infected with the human immunodeficiency virus.

Authors:  U V Comandini; P Maggi; P Santopadre; R Monno; G Angarano; V Vullo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-10       Impact factor: 3.267

8.  Prevalence of Chlamydia pneumoniae specific antibodies in different clinical situations and healthy subjects in Izmir, Turkey.

Authors:  M Gencay; D Dereli; E Ertem; D Serter; M Puolakkainen; P Saikku; B Boydak; S Dereli; B Ozbakkaloglu; A Yorgancioglu; E Tez
Journal:  Eur J Epidemiol       Date:  1998-07       Impact factor: 8.082

9.  Evaluation of PCR, culture, and serology for diagnosis of Chlamydia pneumoniae respiratory infections.

Authors:  R P Verkooyen; D Willemse; S C Hiep-van Casteren; S A Joulandan; R J Snijder; J M van den Bosch; H P van Helden; M F Peeters; H A Verbrugh
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

Review 10.  Acute bronchitis: state of the art diagnosis and therapy.

Authors:  Fernando J Martinez
Journal:  Compr Ther       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.